Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development
Year: 2026
Type: article
DOI: 10.17615/fp4x-ce33
Authors: Uetrecht, Jack P, Bonkovsky, Herbert L, Pehlivanov, Nonko D, Li, Hewei, Chalasani, Naga P, Patel, Niti N, Avigan, Mark I, Price, Karen D, Haque, Syed Asif, Vierling, John M, Fontana, Robert J, Freston, James W, Kiazand, Alexandre, Lewis, James H, Harrison, Melanie J, Watkins, Paul B, Regev, Arie, Patwardhan, Meenal, Kullak-Ublick, Gerd A, Omokaro, Stephanie O, Miller, Ethan D, Di Bisceglie, Adrian M
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7130388188